Many pharmaceutical companies argue that they rely on the revenue generated from sales in the US in order to deliver new and innovative medical advances. While drug prices have been under ...

Sanofi is following in the footsteps of a number of its peers in pharma with a plan to spin off ... as a standalone business since 2020 and had sales of €1.245 billion in the third quarter ...